Supreme (AIM: SUP) shares fall 6% as record revenue masks flat EBITDA and vape margin pressure

Supreme plc (AIM: SUP) reported record FY2026 revenue of £270.2 million, up 17%, as vaping growth and acquisitions expanded its consumer goods portfolio. Adjusted EBITDA remained almost unchanged at £40.6 million, while profit before tax fell 14% to £26.7 million and adjusted earnings per share declined 13% to 18.9 pence. Gross margin narrowed from 32% to 29%, mainly because pod-based vaping products generated lower margins than the disposable products they replaced. Supreme shares fell approximately 6% following the results as investors questioned whether rapidly expanding sales can begin producing proportionate earnings growth.

Why did Supreme’s 17% revenue growth produce almost no increase in adjusted EBITDA?

The central issue within Supreme’s FY2026 results is the widening gap between revenue growth and profit growth. Revenue increased by £39.1 million, but adjusted EBITDA rose by only £0.1 million. This means a significant portion of the additional sales did not translate into incremental operating earnings.

The change reflects product mix rather than a collapse in underlying demand. Vaping revenue increased 15% to £148.1 million, but much of the growth came from pod-based devices introduced after the United Kingdom banned disposable vapes in June 2025. Pod systems typically generate lower gross margins than the disposable products they replaced, particularly during the initial purchasing and supply-chain transition.

Supreme also absorbed the costs associated with integrating recent acquisitions and expanding manufacturing infrastructure. The company invested £6 million in projects including The Hive wellness manufacturing facility and The Plant tea operation. These investments are intended to support future margin expansion, but during FY2026 they contributed costs before reaching full production efficiency.

Group gross profit still increased 7% to £78.9 million. However, that growth was considerably slower than the 17% increase in revenue, reducing the gross margin by three percentage points. Adjusted EBITDA margin consequently fell from approximately 17.5% to 15%.

This is not necessarily evidence that the diversification strategy is failing. It does show that Supreme’s enlarged portfolio is currently producing lower average profitability than the business generated before the vape transition and recent acquisition programme.

Investors will now expect management to demonstrate that manufacturing efficiencies, acquisition synergies and purchasing discipline can close that margin gap. Record sales are useful, but shareholders generally prefer records that survive the journey to the bottom of the income statement.

How did Supreme protect vaping revenue after the United Kingdom disposable vape ban?

Supreme’s ability to increase Vaping division revenue by 15% was one of the strongest operational achievements in the results. The disposable vape ban represented a substantial threat because retailers and consumers had to transition rapidly toward reusable pod systems and compliant e-liquid formats.

Supreme retained all its major retail customers during the transition. The company expanded its portfolio through brands including Hayati and IVG, entered additional markets such as Spain and rolled out pod devices during the second quarter. These initiatives helped Vaping revenue increase by £19.1 million to £148.1 million.

The business also continued producing approximately 70 million bottles of 10-millilitre e-liquid annually from its Manchester manufacturing operation. This manufacturing scale gives Supreme control over production, compliance and supply availability while creating opportunities to manufacture products for third-party brands.

However, the revenue resilience came at a cost. Pod-based products generate structurally lower margins across the market than disposable vapes. Supreme also required time to optimise purchasing volumes and supplier terms within the new category.

The transition therefore protected the size of the Vaping division but changed its economics. The next challenge is to improve the profit contribution without losing the customers and volumes secured during FY2026.

Vaping remains Supreme’s largest division, accounting for almost 55% of group revenue. Despite acquisitions across tea, soft drinks, weight management and household products, the company remains materially exposed to vaping regulation and consumer behaviour.

That concentration creates both an advantage and a risk. Supreme possesses manufacturing scale, retailer relationships and compliance capabilities that smaller vape suppliers may struggle to match. However, any regulatory or demand shock affecting vaping can still have a disproportionate impact on group earnings.

Could the new Vaping Products Duty help Supreme gain market share despite lower volumes?

The introduction of the United Kingdom Vaping Products Duty in October 2026 will become the next major test for Supreme. The duty will increase the price of compliant vaping products and require manufacturers to manage tax stamps, packaging requirements, duty suspension arrangements and additional warehouse controls.

Supreme has already adapted manufacturing processes and reconfigured parts of its warehousing network. This preparation should reduce disruption when the duty takes effect, although the final consumer response remains uncertain.

Higher retail prices could lower overall vape volumes or encourage some users to move between products. Ten-millilitre e-liquids may face particular pressure because the tax increase could represent a relatively large proportion of their current selling price.

Supreme has internally considered a severe scenario in which demand attributable to its 10-millilitre e-liquid products disappears entirely. The company concluded that even such an outcome would not threaten its ability to continue operating, reflecting the protection offered by its broader portfolio and positive cash position.

The more optimistic case is that the duty accelerates market consolidation. Smaller manufacturers may struggle with the working capital, systems, tax administration and compliance infrastructure required under the new regime. Retailers could respond by concentrating orders among larger suppliers capable of maintaining uninterrupted supply.

Supreme may therefore lose some category volume while gaining a larger share of the remaining compliant market. Contract manufacturing could become particularly attractive if smaller brands decide that outsourcing production is more economical than adapting their own facilities.

There is also a risk that higher duties encourage illicit or non-compliant trade rather than eliminating it. Supreme’s opportunity depends partly on regulators enforcing the rules effectively. Compliant suppliers cannot benefit fully from consolidation if illegal products continue reaching consumers without bearing equivalent taxes or compliance costs.

Is Supreme’s Drinks and Wellness expansion creating a credible second growth engine?

Drinks and Wellness revenue increased 60% to £69.3 million, compared with just £23.9 million two years earlier. The division now includes Sci-MX, Clearly Drinks, Typhoo Tea and SlimFast, alongside newly signed licensing arrangements involving Carabao and Tonino Lamborghini.

The division’s growth was heavily influenced by acquisitions. SlimFast contributed £8.9 million during its first five months under Supreme ownership, while the full-year effect of Clearly Drinks and Typhoo Tea added approximately £16.2 million.

Organic development also contributed. Soft Drinks revenue increased about 41% to £26.3 million as Supreme introduced Clearly Drinks products to more of its existing retail customers. The company has used a smaller pilot manufacturing line to attract emerging drinks brands that do not initially require the volumes handled by larger production lines.

This strategy demonstrates how Supreme intends to create value from acquisitions. The company is not relying solely on restoring individual brands. It is placing acquired products into a common distribution network, introducing them to existing retailers and moving more manufacturing in-house.

SlimFast expands Supreme’s access to weight-management consumers and retailers including Boots and Superdrug. Typhoo Tea gives the company exposure to hot beverages, while Clearly Drinks adds soft-drink manufacturing capacity. Sci-MX provides an established sports-nutrition platform that can use The Hive for protein powders and contract manufacturing.

The challenge is turning portfolio expansion into group-level margin improvement. Drinks and Wellness produced gross profit of £21.5 million on revenue of £69.3 million, implying a margin of about 31%. That is attractive relative to some categories, but acquisition integration, manufacturing utilisation and brand investment will determine how much ultimately reaches EBITDA.

The new facilities must generate enough additional volume to justify the capital committed. Underutilised manufacturing capacity can quickly become a fixed-cost burden, especially when consumer brands compete for limited shelf space and promotional support.

Supreme will also need to avoid collecting brands faster than it can develop them. The portfolio now includes almost 30 owned or exclusively licensed brands. Each additional brand creates potential cross-selling opportunities, but it also requires management attention, working capital and a clear position within the retail market.

What do SlimFast, Typhoo Tea and Clearly Drinks reveal about Supreme’s acquisition model?

Supreme has focused on acquiring recognisable consumer brands or production capabilities that can be purchased at valuations below the cost of developing equivalent operations organically. The company then uses manufacturing, logistics and retailer relationships to improve distribution and profitability.

The SlimFast and 1001 carpet-care acquisitions cost a combined £22.3 million and are expected to generate approximately £6.5 million of annualised adjusted EBITDA. On that basis, the initial acquisition multiple appears attractive, provided the expected earnings are delivered and sustained.

SlimFast offers the clearest cross-selling opportunity because it brings brand recognition and relationships with pharmacies, supermarkets and online retailers. Supreme can potentially lower manufacturing and distribution costs while adding new products through The Hive.

Typhoo Tea represents a more operationally intensive turnaround. Supreme has rebuilt domestic manufacturing through The Plant, which produced approximately 380 million tea bags during its first year. The opportunity is to restore an established brand while using the facility for other customers and products.

Clearly Drinks offers a different form of value. The manufacturing business is tied to its water source in northeast England and must continue operating relatively independently. This limits some central cost synergies, but the facility gives Supreme capabilities that would have been expensive to construct from scratch.

These acquisitions have transformed the composition of Supreme’s revenue. The company is becoming less dependent on batteries, lighting and vaping, although vaping remains dominant.

The acquisition model will ultimately be judged by return on invested capital rather than revenue acquired. Supreme’s stronger cash generation and positive adjusted net cash position indicate that the business has so far financed expansion without placing the balance sheet under excessive strain. The unresolved question is whether profit growth will now catch up with the larger revenue base.

Why is Supreme’s Electricals and Household division continuing to contract?

Electricals and Household revenue declined 10% to £52.8 million. Gross profit fell from £12.2 million to £9 million, reflecting weaker conditions across batteries and lighting.

The Batteries business was affected by Panasonic’s withdrawal from the European market, which disrupted product availability while Supreme replaced the lost volumes with alternative brands. Amazon also changed its distribution model for global brands, reducing the role of resellers including Supreme and some of its customers.

Lighting demand remained under pressure from a structurally declining market. Longer-lasting products reduce replacement frequency, while intense price competition limits opportunities to expand margins.

The acquisition of the 1001 carpet-care brand added £2 million of revenue and broadened the division beyond batteries and lighting. The product also gives Supreme access to household-cleaning demand that is less exposed to the structural decline affecting traditional electrical products.

Management regards the division as a low-maintenance, cash-generative operation rather than a major growth engine. That positioning is reasonable, but the decline still matters because falling gross profit from established categories partially offsets gains made elsewhere.

Supreme may continue using acquisitions to introduce adjacent household brands into the existing distribution network. The risk is that diversification becomes a permanent exercise in replacing revenue lost from older categories rather than creating meaningful group profit growth.

A disciplined approach would involve managing the declining battery and lighting activities for cash while investing selectively in household products with stronger margins and more stable demand.

Has Supreme’s cash generation improved enough to support further acquisitions?

Operating cash flow increased 29% to £32.4 million, while adjusted net cash rose from £1.2 million to £7.5 million. Statutory net debt, which includes lease liabilities, fell 40% to £7.4 million.

This cash performance is important because Supreme spent £12.9 million on acquisitions during the year and invested another £6 million in manufacturing capabilities. Ending the period in an adjusted net cash position after these outflows indicates that the underlying business remains strongly cash generative.

The company also has access to a £40 million asset-based lending facility with HSBC extending to March 2028. Because Supreme finished FY2026 with adjusted net cash, exposure to higher borrowing rates is currently limited.

Management has indicated that acquisitions remain part of the strategy, although integration has become a greater priority after the portfolio doubled over a relatively short period. This pause is sensible because the operational value of recent purchases must be demonstrated before further complexity is added.

The proposed total dividend increased 4% to 5.4 pence per share. At a share price near 146 pence, that represents a prospective yield of approximately 3.7%. The distribution appears supportable by cash generation, although dividend growth will depend on earnings rather than one year of working-capital improvement.

Supreme’s balance sheet provides room for additional deals, but financial capacity should not be mistaken for strategic necessity. The company does not need another acquisition merely to maintain the appearance of momentum.

The stronger capital-allocation choice may be to increase utilisation at The Hive and The Plant, integrate SlimFast and 1001, and demonstrate that existing assets can produce higher margins before deploying significant capital again.

Why did Supreme shares fall despite record revenue and stronger cash flow?

Supreme shares traded around 146 pence following the results, down approximately 6% from the previous closing level near 156 pence. The decline appears to reflect the quality of earnings rather than disappointment with headline revenue.

Based on available market data, the shares were approximately 2% to 3% lower over five trading sessions and broadly unchanged compared with the beginning of June. The stock remained within a 52-week range of approximately 124 pence to 205 pence, leaving it about 29% below its annual high.

At the post-results price, Supreme’s market capitalisation was approximately £172 million. The shares traded at roughly 7.7 times adjusted FY2026 earnings and about 9.5 times statutory earnings, depending on which earnings measure investors apply.

That valuation is not demanding for a cash-generative consumer goods business with positive net cash. However, the discount reflects regulatory exposure, acquisition risk, declining legacy categories and uncertainty about whether recent revenue growth can restore margins.

The market had also been prepared for strong results after Supreme upgraded FY2026 expectations in April. The final revenue figure exceeded the earlier indication of approximately £265 million, but adjusted EBITDA remained at the expected £40.6 million. Investors therefore received more revenue without an accompanying profit upgrade.

Sentiment may improve if margins stabilise and FY2027 EBITDA begins growing. Conversely, further revenue expansion without profit conversion could strengthen the argument that acquisitions and lower-margin vaping products are diluting the economics of the group.

The share-price reaction does not suggest that investors have rejected Supreme’s strategy. It shows that the burden of proof has shifted. Management must now demonstrate operating leverage after several years spent expanding the portfolio.

What must Supreme deliver in FY2027 to rebuild investor confidence?

The first requirement is renewed EBITDA growth. Supreme has guided that current trading is in line with market expectations, but the company needs to show that manufacturing utilisation, acquisition synergies and purchasing improvements can increase earnings faster than overheads.

Gross-margin stabilisation will be closely watched. Pod-based vaping products may remain less profitable than disposables, but improved procurement and larger volumes should reduce some of the initial pressure. Drinks and Wellness must also contribute a greater proportion of higher-margin sales.

The implementation of the Vaping Products Duty will be the largest external catalyst. Supreme needs to retain retailers, manage tax and packaging changes without disruption and capture market share from weaker competitors. Investors will distinguish between genuine consolidation benefits and management optimism based on competitors theoretically leaving the market.

SlimFast must deliver its expected annual earnings contribution, while The Hive should begin demonstrating higher utilisation through owned brands and contract-manufacturing customers. Typhoo Tea and The Plant must similarly show that restored production can create durable economics rather than merely preserve a familiar consumer name.

International expansion provides another potential source of growth. Supreme has established distribution infrastructure in Hong Kong and is exploring opportunities in China and the Middle East. These markets could extend the value of owned and licensed brands, but overseas investment should remain proportionate to proven demand.

Supreme enters FY2027 with a stronger balance sheet, broader portfolio and meaningful manufacturing assets. The company has successfully defended its largest business through a major regulatory change. The next stage is more demanding because investors no longer need proof that Supreme can grow revenue. They need proof that the enlarged business can grow profit.

Key takeaways on what Supreme’s FY2026 results mean for investors and competitors

• Supreme’s 17% revenue growth did not translate into adjusted EBITDA growth, exposing weaker operating leverage across the enlarged portfolio.
• Gross margin fell from 32% to 29% as lower-margin pod systems replaced disposable vaping products.
• Vaping revenue increased 15% to £148.1 million despite the United Kingdom disposable vape ban.
• The October 2026 Vaping Products Duty could reduce category volumes while forcing smaller competitors to exit or outsource manufacturing.
• Drinks and Wellness revenue increased 60% to £69.3 million following the integration of SlimFast, Typhoo Tea and Clearly Drinks.
• Supreme’s manufacturing investments must now generate higher utilisation and margins to justify the capital committed.
• Electricals and Household revenue declined 10%, confirming that batteries and lighting are managed cash assets rather than growth businesses.
• Operating cash flow increased 29%, allowing Supreme to fund acquisitions and manufacturing investment while ending FY2026 with adjusted net cash.
• Supreme shares fell around 6% because investors focused on flat EBITDA, lower earnings and margin compression rather than record revenue.
• FY2027 investor sentiment will depend on Vaping Products Duty execution, acquisition integration and evidence that profit growth is catching up with sales.